Literature DB >> 32296823

Fast-growing oligodendrogliomas are aggressive tumors-the real life biomarker?

Marjolein Geurts1, Martin J van den Bent1.   

Abstract

Entities:  

Keywords:  growth rate; oligodendroglioma; prognosis

Mesh：

Substances：

Year:  2020        PMID： 32296823      PMCID： PMC7339876          DOI： 10.1093/neuonc/noaa097

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  11 in total

1.  Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.

Authors:  Johan Pallud; Marie Blonski; Emmanuel Mandonnet; Etienne Audureau; Denys Fontaine; Nader Sanai; Luc Bauchet; Philippe Peruzzi; Marc Frénay; Philippe Colin; Rémy Guillevin; Valérie Bernier; Marie-Hélène Baron; Jacques Guyotat; Hugues Duffau; Luc Taillandier; Laurent Capelle
Journal:  Neuro Oncol       Date:  2013-02-07       Impact factor: 12.300

2.  Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults.

Authors:  Alexandre Roux; Arnault Tauziede-Espariat; Marc Zanello; Sophie Peeters; Gilles Zah-Bi; Eduardo Parraga; Myriam Edjlali; Emmanuèle Lechapt; Natalia Shor; Luisa Bellu; Giulia Berzero; Didier Dormont; Edouard Dezamis; Fabrice Chretien; Catherine Oppenheim; Marc Sanson; Pascale Varlet; Laurent Capelle; Frédéric Dhermain; Johan Pallud
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

3.  Continuous growth of mean tumor diameter in a subset of grade II gliomas.

Authors:  Emmanuel Mandonnet; Jean-Yves Delattre; Marie-Laure Tanguy; Kristin R Swanson; Antoine F Carpentier; Hugues Duffau; Philippe Cornu; Rémy Van Effenterre; Ellsworth C Alvord; Laurent Capelle
Journal:  Ann Neurol       Date:  2003-04       Impact factor: 10.422

4.  IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.

Authors:  Olatz Etxaniz; Cristina Carrato; Itziar de Aguirre; Cristina Queralt; Ana Muñoz; José L Ramirez; Rafael Rosell; Salvador Villà; Rocio Diaz; Ana Estival; Pilar Teixidor; Alberto Indacochea; Sara Ahjal; Laia Vilà; Carme Balañá
Journal:  J Neurooncol       Date:  2017-09-07       Impact factor: 4.130

5.  The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.

Authors:  Maarten M J Wijnenga; Pim J French; Hendrikus J Dubbink; Winand N M Dinjens; Peggy N Atmodimedjo; Johan M Kros; Marion Smits; Renske Gahrmann; Geert-Jan Rutten; Jeroen B Verheul; Ruth Fleischeuer; Clemens M F Dirven; Arnaud J P E Vincent; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

6.  Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.

Authors:  Kosuke Aoki; Hideo Nakamura; Hiromichi Suzuki; Keitaro Matsuo; Keisuke Kataoka; Teppei Shimamura; Kazuya Motomura; Fumiharu Ohka; Satoshi Shiina; Takashi Yamamoto; Yasunobu Nagata; Tetsuichi Yoshizato; Masahiro Mizoguchi; Tatsuya Abe; Yasutomo Momii; Yoshihiro Muragaki; Reiko Watanabe; Ichiro Ito; Masashi Sanada; Hironori Yajima; Naoya Morita; Ichiro Takeuchi; Satoru Miyano; Toshihiko Wakabayashi; Seishi Ogawa; Atsushi Natsume
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

7.  Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.

Authors:  Lee A D Cooper; Daniel J Brat; Sameer H Halani; Safoora Yousefi; Jose Velazquez Vega; Michael R Rossi; Zheng Zhao; Fatemeh Amrollahi; Chad A Holder; Amelia Baxter-Stoltzfus; Jennifer Eschbacher; Brent Griffith; Jeffrey J Olson; Tao Jiang; Joseph R Yates; Charles G Eberhart; Laila M Poisson
Journal:  NPJ Precis Oncol       Date:  2018-11-06

8.  Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma.

Authors:  Maarten M J Wijnenga; Pim J French; Hendrikus J Dubbink; Winand N M Dinjens; Peggy N Atmodimedjo; Johan M Kros; Ruth Fleischeuer; Clemens M F Dirven; Arnaud J P E Vincent; Martin J van den Bent
Journal:  J Neurooncol       Date:  2018-04-16       Impact factor: 4.130

9.  CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.

Authors:  Romain Appay; Caroline Dehais; Claude-Alain Maurage; Agusti Alentorn; Catherine Carpentier; Carole Colin; François Ducray; Fabienne Escande; Ahmed Idbaih; Aurélie Kamoun; Yannick Marie; Karima Mokhtari; Emeline Tabouret; Nesrine Trabelsi; Emmanuelle Uro-Coste; Jean-Yves Delattre; Dominique Figarella-Branger
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 13.029

10.  Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.

Authors:  Dominique Figarella-Branger; Karima Mokhtari; Caroline Dehais; Anne Jouvet; Emmanuelle Uro-Coste; Carole Colin; Catherine Carpentier; Fabien Forest; Claude-Alain Maurage; Jean-Michel Vignaud; Marc Polivka; Emmanuelle Lechapt-Zalcman; Sandrine Eimer; Gabriel Viennet; Isabelle Quintin-Roué; Marie-Hélène Aubriot-Lorton; Marie-Danièle Diebold; Delphine Loussouarn; Catherine Lacroix; Valérie Rigau; Annie Laquerrière; Fanny Vandenbos; Sophie Michalak; Henri Sevestre; Michel Peoch; François Labrousse; Christo Christov; Jean-Louis Kemeny; Marie-Pierre Chenard; Danchristian Chiforeanu; François Ducray; Ahmed Idbaih
Journal:  Neuro Oncol       Date:  2014-04-09       Impact factor: 13.029
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.